Shareholder Information

Share Capital build-up since inception

Date No. of equity shares allotted Face Value (₹) Issue Price (₹) Consideration Reasons/ Mode of allotment Cumulative Paid-Up Capital (₹) Cumulative no. of Shares
April 26, 1947 1,000 100 100 Cash Initial subscribers to the Memorandum of Association 100,000 1,000
June 30, 1967 5,000 100 Cash Equity shares allotted pursuant to a bonus issue 600,000 6,000
August 28,1979 Sub-division of the equity shares from face value of ₹ 100 each to face value of ₹ 10 each 600,000 60,000
October 4, 1979 600,000 10 N.A. Equity shares allotted pursuant to a bonus issue 6,600,000 660,000
November, 1979 803,600 10 10 Cash Equity shares allotted pursuant to rights issue 14,636,000 1,463,600
June 3, 1991 1,650,000 10 Other than cash Allotment to shareholders of erstwhile Gujarat Glass Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 31,136,000 3,113,600
September 30, 1991 3,113,600 10 N.A. Equity shares allotted pursuant to a bonus issue to the then existing shareholders 62,272,000 6,227,200
October 20, 1992 1,879,836 10 50 Cash Equity shares allotted pursuant to conversion of partly convertible debentures 81,070,360 8,107,036
July 29, 1993 4,053,518 10 N.A. Equity shares allotted pursuant to a bonus issue 121,605,540 12,160,554
February 14, 17 and 19, 1994 3,030,000 10 330 Cash Preferential allotment to 22 allotees 151,905,540 15,190,554
August 4, 1994 2,200,000 10 90 Cash Issued against warrants attached to non-convertible debentures 173,905,540 17,390,554
September 16, 1996 1,039,410 10 Other than cash Allotment to shareholders of erstwhile Sumitra Pharmaceuticals & Chemicals Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 184,299,640 18,429,964
October 10, 1997 9,278,406 10 Other than cash Allotment of 7,505,004 equity shares to shareholders of erstwhile Piramal Healthcare Limited and 1,773,402 equity shares to shareholders of erstwhile Boehringer Mannheim India Limited, pursuant to respective schemes of arrangement under Sections 391-394 of the Companies Act, 1956 277,083,700 27,708,370
February 15, 2000 7,137,781 10 50 Cash Issued against the conversion of warrants held by shareholders of erstwhile Piramal Holdings Limited 348,461,510 34,846,151
March 29, 2000 6,900 10 50 Cash Issued against the conversion of warrants held by shareholders of our Company 348,530,510 34,853,051
August 9, 2000 150 10 50 Cash Issued to G. Ratnavali, one of then shareholder of our Company against the conversion of warrants held by him. 348,532,010 34,853,201
February 15, 2002 3,150,000 10 Other than cash Allotment to shareholders of Rhone-Poulenc (India) Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 380,032,010 38,003,201
January 3, 2005 Subdivision of the equity shares from face value of ₹ 10 to face value of ₹ 2 each 380,032,010 190,016,005
September 25, 2005 18,997,128 2 175 Cash Equity Shares allotted pursuant to rights issue 418,026,266 209,013,133
July 16, 2007 11 2 175 Cash Equity Shares allotted out of the Equity Shares held in abeyance during the rights issue dated September 25, 2005 418,026,288 209,013,144
March 29, 2011 -41,097,100 2 600 Cash Buy back of Equity Shares 335,832,088 167,916,044
June 15, 2011 -705,529 2 600 Cash Buy back of Equity Shares 334,421,030 167,210,515
December 30, 2011 5,352,585 2 2 Other than cash Allotment to shareholders of Piramal Life Sciences Limited pursuant to a scheme of arrangement under Sections 391-394 of the Companies Act, 1956 345,126,200 172,563,100
November 24, 2017 225,000 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 345,576,200 172,788,100
March 8, 2018 7,485,574 2 2380 Cash Equity shares allotted pursuant to rights issue 360,547,348 180,273,674
May 7, 2018 121,200 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 360,789,748 180,394,874
May 15, 2018 197,640 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 361,185,028 180,592,514
July 5, 2018 5269 2 2380 Cash Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company 361,195,566 180,597,783
August 31, 2018 200 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 361,195,966 180,597,983
September 7,2018 85,280 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 361,366,526 180,683,263
September 17,2018 3,715 2 2380 Cash Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company 361,373,956 180,686,978
September 25,2018 302,000 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 361,977,956 180,988,978
October 5,2018 322,240 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 362,622,436 181,311,218
October 26,2018 1,373,240 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 365,368,916 182,684,458
November 16,2018 675,360 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 366,719,636 183,359,818
December 18,2018 52,440 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 36,68,24,516 18,34,12,258
January 16, 2019 186,000 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 36,71,96,516 18,35,98,258
February 4, 2019 441,920 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 36,80,80,356 18,40,40,178
March 14, 2019 404,480 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 36,88,89,316 18,44,44,658
March 19, 2019 2,314 2 2,380 Cash Equity Shares allotted out of the Right Shares held in abeyance under the rights issue of the Company 36,88,93,944 18,44,46,972
April 05, 2019 17,585 2 2,380 Cash Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company 36,89,29,114 18,44,64,557
April 11, 2019 5,48,120 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 37,00,25,354 18,50,12,677
April 22, 2019 1,36,38,080 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 39,73,01,514 19,86,50,757
May 21, 2019 1,93,550 2 2,380 Cash Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company 39,76,88,614 19,88,44,307
May 30, 2019 2,257 2 2,380 Cash Allotment pursuant of shares out of CCD reservation portion under rights issue of the Company 39,76,93,128 19,88,46,564
August 08, 2019 66 2 2,380 Cash Equity Shares allotted out of the Right Shares held in abeyance under the rights issue of the Company 39,76,93,260 19,88,46,630
December 13,2019 3,05,865 2 Other than cash Allotment pursuant to the Scheme of Amalgamation of Piramal Phytocare Limited with Piramal Enterprises Limited 39,83,04,990 199,152,495
January 29, 2020 2,63,85,861 2 1300 Cash Equity Shares allotted pursuant to rights issue vide Letter of Offer dated December 24, 2019 45,10,76,712 22,55,38,356
June 14, 2021 1,15,89,400 2 Other than cash Allotment pursuant to conversion of Compulsorily Convertible Debentures into Equity shares of the Company 47,42,55,512 23,71,27,756
June 28, 2021 15,35,944 2 1300 Cash Allotment of shares out of CCD reservation portion under rights issue of the Company 47,73,27,400 23,86,63,700
September 18, 2023 -1,40,00,000 2 1250 Cash Buy back of Equity Shares 44,93,27,400 22,46,63,700

PEL Dividend history

Financial Year Type of Dividend % Dividend (of face value) Dividend per Share (in Rs.)
2022-23 Final 1,550% 31.00
2021-22 Final 1,650% 33.00
2020-21 Final 1,650% 33.00
2019-20 Final 700% 14.00
2018-19 Final 1400% 28.00
2017-18 Final 1250% 25.00
2016-17 Final 1050% 21.00
2015-16 Interim 875% 17.50
2014-15 Final 1000% 20.00
  Special 1750% 35.00
2013-14 Final 875% 17.50
2012-13 Final 875% 17.50
2011-12 Final 875% 17.50
2010-11 Final 600% 12.00
2009-10 Final 270% 5.40
2008-09 Final 210% 4.20
2007-08 Final 210% 4.20
  Interim 150% 3.00
2006-07 Final 25% 0.50
2005-06 Final 150% 3.00
2004-05 Final 150% 3.00
2003-04 Final 150% 15.00
2002-03 Final 105% 10.50
2001-02 Final 85% 8.50
2000-01 Final 70% 7.00
1999-00 Interim 65% 6.50
1998-99 Final 55% 5.50
  Special 55% 5.50
1997-98 Final 45% 4.50
  Pro – Rata 31.20% 3.12
  Pro – Rata 20.20% 2.02
1996-97 Final 37.50% 3.75
1995-96 Final 32.50% 3.25
1994-95 Final 30% 3.00
1993-94 Final 22.50% 2.25
  Pro – Rata 11.20% 1.12
1992-93 Final 25% 2.50
1991-92 Final 20% 2.00
1990-91 Final 35% 3.50
1989-90 Final 30% 3.00
1988-89 Final 18% 1.80
1987-88 Final 21% 2.10

Access Link to claim refund from IEPF Authority

(to be used by shareholders/claimants whose shares and/or dividend/other amounts have been transferred by the Company to Investor Education and Protection Fund)

Click Here
Nodal Officer

Mr. Bipin Singh

Designation: Company Secretary
Address: Piramal Ananta, Agastya Corporate Park,
Opposite Fire Brigade,
Kamani Junction, LBS Marg
Kurla (West), Mumbai 400070
Maharashtra, India
Tel : + 91 22 3802 3000 / 4000
Email: complianceofficer.pel@piramal.com

Share capital buld-up since inception

Name of the instrument Current Rating Chronology of Rating History
  Type FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
    Dec–22** Oct–22 Jul-22 Apr-22 Aug-21 March March Sep-18 Apr-18
NCD Long Term CARE AA; Stable [ICRA]AA (Stable) CARE AA(Stable) [ICRA]AA(Stable) [ICRA] AA (placed on watch with developing implications)/ CARE AA (Under Credit watch with developing implications) ICRA AA (Negative)
/ CARE AA (Under Credit watch with developing
implications)
ICRA AA (Negative)
/ CARE AA (Stable)
[ICRA]AA (Stable)
/
[CARE]AA (Stable)
[ICRA]AA (Stable)
/
[CARE]AA (Stable)
Short Term [ICRA]A1+ CARE A1+ CARE A1+ CARE A1+ / CRISIL A1+ CARE A1+
(A One Plus)
CP Short Term [ICRA]A1+ CARE A1+ CARE A1+/ CRISIL A1+ CARE A1+
/
CRISIL A1+
ICRA A1+
/
CARE A1+
[ICRA]A1+
/
[CARE]A1+
/
[CRISIL] A1+
[ICRA]A1+
/
[CARE]A1+
Fund Based Long Term CARE AA; Stable/
CARE A1+***
[ICRA]AA (Stable) CARE AA (Stable) [ICRA]AA (Stable) [ICRA] AA (placed on watch with developing implications) [ICRA]AA (Stable)
/
[CARE]AA (Stable)
[ICRA]AA (Stable)
Term Loans Long Term [ICRA]AA (Stable)
/
[CARE]AA (Stable)
[ICRA]AA (Stable)
Non-fund based Short Term [ICRA]A1+ [ICRA]A1+
/
[CARE]A1+
[ICRA]A1+
Fund based Short Term CARE AA; Stable
/
CARE A1+***
[ICRA]A1+ CARE A1+ [ICRA] A1+/CARE A1+ ICRA A1+
/
CARE A1+
[ICRA]A1+
/
[CARE]A1+
[ICRA]A1+
ICD Short Term CARE A1+ CARE A1+ CARE A1+ CARE A1+ [CARE]A1+
PP – MLD Long Term CARE PP-MLD AA; Stable CARE PP-MLD AA; Stable PP-MLD ICRA AA (Negative) PP-MLD [ICRA] AA (Stable)*

*Assigned w.e.f. December 2018

**The rating was issued to PHL Fininvest Private Limited (‘PFPL’) has been transferred to the Company consequent to the merger of PFPL into the Company, pursuant to the sanction of the composite scheme of arrangement by the Hon’ble National Company Law Tribunal, Mumbai Bench vide its order dated 12th August, 2022

***Ratings for the Long-term/ Short-term bank facilities have been combined by CARE and there is no revision in the ratings.

Valuation of Market Linked Debentures

Piramal Enterprises Limited issues Rated, Listed, Secured, Redeemable, Principal Protected Non-Convertible Market Linked Debentures (PPMLDs).

Please review the relevant offer document/memorandum of private placement/pricing supplement relating to the specific PPMLDs for details on the PPMLDs including their risk factors. ICRA Analytics Ltd. has been appointed as the valuation agency for the valuation of these debentures.

As per the Guidelines for Issue and Listing of Structured Products / Market Linked Debentures issued by SEBI, depending on the valuation agency mentioned in the offer document/memorandum of private placement/pricing supplement; the latest and historical valuations provided by the valuation agent will be available as below:

If ICRA is the Valuation Agency: https://icraanalytics.com/home/MldValuation

If CARE is the Valuation Agency: https://www.carerisksolutions.com/file-share

KYC Forms

Form ISR-1 - Request for Registering PAN, KYC details OR Changes/updations there of (only for securities held in physical)

Form ISR-2 - Confirmation of Signature of securities holder by Banker

Form ISR-3 - Declaration for Opting-out of Nomination by holders of physical securities in Listed Companies

Form ISR-4 - Issuance of Securities in dematerialized form in case of Investor Service Requests

Form SH-13 - Nomination Form

Form SH-14 - Cancellation OR Variation of Nomination

Nomination Form

Section 72 of the Companies Act, 2013 provides for Nomination by shareholders of the Company in the prescribed Form No. SH-13. Shareholders are requested to avail of this facility. You may download this form by clicking here. Kindly send a duly filled and signed copy of the same to the Company’s Share Transfer Agents for registration. In case of Joint Holders, all Joint holders are required to sign on the aforesaid form.

The Nomination Form may be cancelled or varied by nominating any other person in place of the present Nominee, by giving such notice in the prescribed Form SH-14. You may download this form by clicking here. Kindly send a duly filled and signed copy of the same to the Company’s Share Transfer Agents for registration.

Where the Nominee is a Minor, the shareholder may appoint any other person in Form SH-14, who shall become entitled to the securities of the Company, in the event of death of the Nominee during his minority.

Cost of Acquisition of PEL and PPL shares
Download as PDF
PEL – Newspaper advertisement for Notice of Record Date
Download as PDF
Final Composite Scheme of Arrangement
Download as PDF
PEL – Intimation of Record Date for ascertaining the Shareholders entitled to receive equity shares of PPL in accordance with the Scheme
Download as PDF
NCLT Final Order dated 12th August, 2022
Download as PDF
Newspaper Advertisement for Notice of Hearing of Petition – 23rd July, 2022
Download as PDF
NCLT Order dated July 19, 2022
Download as PDF
PEL – Transcript of NCLT Convened Meeting of Equity Shareholders on 5th July, 2022
Download as PDF
Voting Results and Consolidated Scrutinizer’s Report of NCLT convened meeting of Equity Shareholders – 5th July, 2022
Download as PDF
Scrutinizer’s Report of NCLT convened meeting of Secured & Unsecured Creditors – 5th July, 2022
Download as PDF
PEL – Proceedings of NCLT Convened Meeting of Equity Shareholders – 5th July, 2022
Download as PDF
PEL – Proceedings of NCLT Convened Meeting of Secured Creditors – 5th July, 2022
Download as PDF
PEL – Proceedings of NCLT Convened Meeting of Unsecured Creditors – 5th July, 2022
Download as PDF
Newspaper advertisement for Corrigendum Order of Rectification – 16th June, 2022
Download as PDF
Newspaper advertisement for NCLT convened meetings – 4th June, 2022
Download as PDF
Due Diligence Certificates on Abridged Prospectus
Download as PDF
NCLT Corrigendum Order of Rectification dated June 3, 2022
Download as PDF
NCLT Notice – Equity Shareholders
Download as PDF
NCLT Notice – Secured Creditors
Download as PDF
NCLT Notice – Unsecured Creditors
Download as PDF
Composite Scheme of Arrangement
Download as PDF
Valuation Report
Download as PDF
Audit Committee Report
Download as PDF
Fairness Opinion
Download as PDF
Pre and Post Shareholding Pattern
Download as PDF
Audited Financials of last 3 years of the unlisted entities
Download as PDF
Accounting treatment certificate
Download as PDF
Compliance Report
Download as PDF
Independent Directors Report
Download as PDF
Final Observation Letter – BSE
Download as PDF
Final Observation Letter – NSE
Download as PDF
Response to Observation Letter – BSE
Download as PDF
Response to Observation Letter – NSE
Download as PDF
NCLT Order dated May 12, 2022
Download as PDF

Frequently Asked Questions

Procedure to be followed by Equity Shareholders holding Equity Shares in the dematerialised form
  • Eligible Shareholders who desire to tender their Equity Shares in the electronic form under the Buyback would have to do so through their respective Selling Member (“Broker”) by indicating to their Broker the details of Equity Shares they intend to tender under the Buyback.
  • The lien shall be marked by the Broker in the demat account of the Shareholders for the shares tendered in tender offer.
  • The Eligible Shareholders will have to ensure that they keep the DP account active and unblocked to receive credit in case of return of Equity Shares due to rejection or due to prorated Buyback decided by the Company. Further, Eligible Shareholders will have to ensure that they keep the saving account attached with the DP account active and updated to receive credit remittance due to acceptance of Buyback of shares by the Company.
    For more details, please refer procedure as laid out in Paragraph 20.22 of the PEL – Buyback Letter of Offer.
Procedure to be followed by Eligible Shareholders holding Equity Shares held in the Physical form
  • Eligible Shareholders who are holding physical Equity Shares and intend to participate in the Buyback will be required to approach their respective Stock Brokers along with the complete set of documents for verification procedures to be carried out as follows:
    1. original share certificate(s);
    2. valid share transfer form(s) (i.e., form SH-4) duly filled and signed by the transferors (i.e. by all registered Eligible Shareholders in same order and as per the specimen signatures registered with the Company) and duly witnessed at the appropriate place authorizing the transfer in favour of the Company;
    3. self-attested copy of the Eligible Shareholder’s PAN Card;
    4. any other relevant documents such as power of attorney, corporate authorization (including board resolution/ specimen signature), notarized copy of death certificate and succession certificate or probated will, if the original shareholder has deceased, etc., as applicable.
    5. In addition, if the address of an Eligible Shareholder has undergone a change from the address registered in the Register of Members of the Company, such Eligible Shareholder would be required to submit a self-attested copy of address proof consisting of any one of the following documents: valid Aadhaar Card, Voter Identity Card or Passport.
  • Based on the documents mentioned above, the concerned Stock Broker shall place the bid on behalf of the Eligible Shareholder holding Equity Shares in physical form who wishes to tender Equity Shares in the Buyback using the acquisition window of the Stock Exchanges. Upon placing the bid, the Stock Broker shall provide a TRS generated by the Stock Exchanges’ bidding system to the Eligible Shareholder. The TRS will contain the details of the order submitted like Folio No., Certificate No., Distinctive No., No. of Equity Shares tendered, etc.
  • The Stock Broker has to deliver the original share certificate(s) and documents (as mentioned above) along with TRS either by registered post or courier or hand delivery to the Registrar within 2 days of closure of the Tendering Period. The envelope should be super scribed as “PEL Buyback Offer 2023”. One copy of the TRS will be retained by Registrar and it will provide acknowledgement of the same to the Stock Broker/ Eligible Shareholder.
  • In case any Eligible Shareholder has submitted Equity Shares in physical form for dematerialization, such Equity Shareholders should ensure that the process of getting the Equity Shares dematerialized is completed well in time so that they can participate in the Buyback before Buyback Closing Date.
    For more details please refer procedure as laid out in Paragraph 20.23 of the PEL – Buyback Letter of Offer.
How can I find out my entitlement in the Buyback

The Eligible Shareholders can visit https://web.linkintime.co.in/Offer/Default.aspx to get duly overprinted tender form containing their entitlements.

Contact details of the Manager and Registrar to the Buyback Offer for further queries:
MANAGER TO THE BUYBACK REGISTRAR TO THE BUYBACK
jm Financial
JM Financial Limited
7th Floor, Cnergy,
Appasaheb Marathe Marg, Prabhadevi,
Mumbai – 400025, Maharashtra, India
Tel.: +91 22 6630 3030
Fax: +91 22 6630 3330
Email: piramal.buyback2023@jmfl.com
Website: www.jmfl.com
Contact Person: Ms.PracheeDhuri
Link Intime India Private Limited
C 101, 1st Floor, 247 Park,
L B S Marg, Vikhroli West,
Mumbai – 400083, Maharashtra, India
Tel.: +91 8108114949
Fax: +91 22 4918 6195
Email: Piramal.buyback2023@linkintime.co.in
Website: www.linkintime.co.in
Contact Person: Mr. Sumeet Deshpande

Application Forms can be downloaded from any of the following sites:

Lead Manager Website URL Details of Contact Person
A. K. Capital Services Limited A.K.Stockmart (via Indiabonds) Vaibhav Nangare
Email: vaibhav.nangare@akgroup.co.in
Call: 022 67544753/ 9820675821/ 080-6919 9888
contactus@indiabonds.com
JM Financial Services JM Financial Services T N Kumar / Sona Verghese
Call: +91 22 6136 3400 / 9833202421
Email: tn.kumar@jmfl.com / sona.verghese@jmfl.com
Nuvama Wealth and Investment Limited Nuvama Wealth Sheetal Parab
Call: +91 9867329422
Email: Sheetal.Parab@nuvama.com
Trust Investment Advisors Private Limited Trustgroup Amar Andhari: 022 4224 5012
Komal Mehta: 022 4224 5256
Rahul Kumar Gupta: 022 4224 5217
Email: trustsecurities@trustgroup.in
FY2 024
Copyright © 2024 Piramal Enterprises limited. All Rights Reserved.